Rapamycin-Induced Autophagy Enhances Lipid Breakdown and Ameliorates Lipotoxicity in Atlantic Salmon Cells

Study Background and Research Question

Autophagy is a fundamental cellular process that recycles damaged organelles, misfolded proteins, and other cellular debris, maintaining homeostasis in eukaryotic cells. While the breakdown of lipids through selective autophagy (lipophagy) is well-studied in mammals, limited information exists for non-model organisms such as Atlantic salmon (Salmo salar), a species of major commercial importance in aquaculture. Given that modern aquaculture practices increasingly use plant-based oils, which alter lipid profiles and promote metabolic stress, understanding autophagy’s role in lipid regulation is crucial for improving fish health and welfare. The central question addressed by this study was whether autophagic pathways responsible for lipid droplet breakdown, and their protective effects against lipotoxicity, are conserved and functionally significant in Atlantic salmon cells (Phadwal et al., 2025).

Key Innovation from the Reference Study

The study’s principal innovation lies in demonstrating that pharmacological induction of autophagy via rapamycin enhances lipid droplet breakdown and mitigates lipotoxicity in a macrophage-like cell line (SHK-1) derived from Atlantic salmon. This work not only establishes a cellular model for studying lipotoxicity in fish but also provides molecular evidence that key autophagy mechanisms involved in lipid metabolism are conserved beyond mammals. The identification of specific lipogenic proteins as likely autophagic cargo further uncovers novel aspects of lipid regulation in an aquaculture-relevant species.

Methods and Experimental Design Insights

The authors employed a multi-omics approach combining global lipidomics and proteomics on SHK-1 cells. Cells were subjected to experimental lipid overload to induce lipotoxic stress, followed by treatment with rapamycin, a known mTOR inhibitor and autophagy activator. Rapamycin’s effect on autophagy was evaluated by monitoring canonical markers, notably LC3 flux and ATG13 phosphorylation, which are widely accepted as reliable readouts for autophagy induction and flux measurement. The resulting lipid and protein changes were quantitatively assessed to elucidate the pathways affected by enhanced autophagy.

Protocol Parameters

• Cell model: SHK-1 (salmon head kidney-derived) cell line, suitable for macrophage-like functional assays.
• Lipid overload induction: Exposure to exogenous fatty acids to generate lipotoxic stress before autophagy modulation.
• Autophagy induction: Rapamycin treatment (concentration and duration optimized for robust mTOR inhibition; specific conditions detailed in the reference study).
• Autophagy readouts: LC3 flux measurement and ATG13 phosphorylation blockade to confirm pathway activation.
• Multi-omics profiling: Integration of lipidomics and proteomics to systematically capture lipid species and protein cargo affected by autophagy.

Core Findings and Why They Matter

The study found that rapamycin-induced autophagy significantly enhances the clearance of lipid droplets and reduces accumulation of toxic lipid species such as ceramides and diacylglycerols in SHK-1 cells. Notably, rapamycin treatment facilitated the storage of unsaturated triacylglycerols (TAGs) and suppressed the abundance of key lipogenic proteins, including fatty acid elongase 6 and fatty acid binding protein 2. Proteomic analysis further suggested that these proteins are targeted for autophagic degradation, implicating autophagy in the direct regulation of lipid metabolism beyond mere lipid droplet turnover.

These results imply that autophagy not only protects salmon cells from lipotoxic stress but also fine-tunes lipid metabolic pathways relevant to aquaculture nutrition. The establishment of this model provides a valuable framework for future studies aimed at mitigating negative effects of plant-based diets on fish health (Phadwal et al., 2025).

Comparison with Existing Internal Articles

Recent internal reviews have highlighted the utility of selective ULK1 kinase inhibitors, such as MRT68921, for dissecting autophagy initiation and regulation in diverse cell models (EPGLabs: MRT68921 overview), (AVL-301: ULK1/2 inhibition and lipid metabolism). While the reference study employs rapamycin to activate autophagy, these internal articles discuss the use of potent inhibitors to block ULK1/2 activity, thereby providing a complementary approach for dissecting the autophagy signaling pathway. For example, MRT68921 enables precise inhibition of early autophagy events, as confirmed by robust blockade of ATG13 phosphorylation and LC3 flux, facilitating mechanistic studies of autophagy inhibition and its downstream effects on lipid handling. The integration of these pharmacological tools can help clarify the bidirectional influence between autophagy and lipid metabolism in both mammalian and non-mammalian systems.

Furthermore, recent findings that AMPK can suppress ULK1 during energy stress (STAT5: AMPK-ULK1 regulation) underscore the complexity of autophagy regulation, warranting careful selection and interpretation of pathway modulators in experimental design.

Limitations and Transferability

This study is primarily limited by its in vitro design using the SHK-1 cell line; in vivo relevance to whole organism physiology, especially in the context of aquaculture production, requires further validation. The use of rapamycin, while effective for pathway activation, also exerts pleiotropic effects beyond autophagy, complicating the isolation of autophagy-specific outcomes. Additionally, the transferability of these findings to other fish species or to different tissue types within salmon remains to be tested. However, the demonstration of conserved autophagic mechanisms in fish macrophage-like cells provides a robust foundation for subsequent translational research.

Why this cross-domain matters, maturity, and limitations

The translational bridge between mammalian and fish autophagy research is of practical importance for both basic biology and aquaculture health management. The conservation of core autophagy machinery, as evidenced by similar responses to mTOR inhibition and identification of conserved protein cargos, suggests that tools and insights from mammalian systems may be applicable in fish. Nevertheless, species-specific differences in lipid metabolism and diet-induced stress responses necessitate direct experimental validation in target organisms, as highlighted by the present study.

Research Support Resources

For researchers seeking to further dissect autophagy signaling in fish or mammalian cells, particularly regarding the initiation phase, the MRT68921 dual autophagy kinase ULK1/2 inhibitor (SKU B6174) offers a potent and selective means to inhibit ULK1/2, enabling controlled studies of autophagy inhibition, ATG13 phosphorylation blockade, and LC3 flux measurement. As indicated in APExBIO product documentation, MRT68921 is intended for research use only and has been widely utilized in preclinical model systems to interrogate autophagy pathways. Its use may help clarify the specific contributions of ULK1/2-mediated autophagy in lipid metabolism and other cellular processes relevant to aquaculture and metabolic research.